Core Viewpoint - Henry Schein, Inc. reported strong third-quarter earnings and raised its 2025 guidance, indicating positive momentum despite some downward estimate revisions in the market [2][12][15] Financial Performance - Adjusted EPS for Q3 2025 was $1.38, a 13.1% increase year-over-year, surpassing the Zacks Consensus Estimate by 8.7% [2] - Net sales reached $3.34 billion, reflecting a 5.4% year-over-year growth and beating the Zacks Consensus Estimate by 2% [3] - Gross profit totaled $1.03 billion, a 3.3% increase year-over-year, although gross margin contracted by 56 basis points to 30.7% due to a 6% rise in the cost of sales [8] Segment Analysis - Global Distribution and Value-Added Services sales rose 4.8% year-over-year to $2.84 billion, exceeding the forecast of $2.77 billion [4] - Global Dental Distribution merchandise sales increased by 2.9% in constant currencies, while equipment sales grew by 3.4% [5] - Global Specialty Products sales totaled $369 million, up 5.9% year-over-year, driven by strong dental implant and endodontics sales [6] - Global Technology segment sales reached $173 million, a 9.7% increase, attributed to cloud-based software adoption and new revenue cycle management solutions [7] Cost and Expenses - SG&A expenses increased by 5% to $760 million, with adjusted operating profit down 1.1% year-over-year to $266 million [9] Liquidity and Share Repurchase - Cash and cash equivalents at the end of Q3 were $136 million, down from $145 million in Q2, with cumulative net cash from operating activities at $331 million, significantly lower than the previous year's $644 million [10] - The company repurchased approximately 3.3 million shares at an average price of $68.62, totaling around $229 million, with $980 million authorized for future repurchases [11] Updated Guidance - The full-year 2025 adjusted EPS forecast was raised to a range of $4.88 to $4.96, with projected revenue growth increased to 3-4% [12] Market Position and Estimates - Despite strong performance, estimates have trended downward recently, leading to a Zacks Rank 3 (Hold) for the stock [13][15] - Henry Schein's VGM Score is C, with a subpar Growth Score of D and a better Momentum Score of C, indicating mixed investor sentiment [14]

Kroger stock is not expensive -- if only it can grow fast enough.Kroger (KR 4.73%) stock slid 4.9% through 12:10 p.m. ET Thursday after beating on earnings, but missing on sales this morning.Analysts forecast Kroger would earn an adjusted $1.03 per share on sales of $34.2 billion in its Q3 earnings report. Kroger actually earned $1.05 per share, but its sales fell short at $33.9 billion. Kroger Q3 earningsThis news gets worse. Same-store sales increased 2.6% year over year, but total revenue still sank 0.9 ...

Group 1: Airline Industry - Citi initiated coverage of United Airlines (UAL) with a Buy rating and a price target of $132, citing a positive setup for airlines with an "elongated mid-cycle" beginning in 2026 [1] - Citi also started coverage of Delta Air Lines (DAL) and American Airlines (AAL) with Buy ratings, while Southwest Airlines (LUV) received a Neutral rating [1] Group 2: Aerospace Industry - Susquehanna initiated coverage of GE Aerospace (GE) with a Positive rating and a price target of $350, highlighting that GE powers three out of every four commercial engine flights globally with an installed base of over 45,000 commercial engines and over 25,000 military engines, both growing at mid-single digits [1] Group 3: Food Industry - Jefferies resumed coverage of Hershey (HSY) with a Hold rating and a price target of $181, noting that while Hershey has managed cocoa cost pressures through various strategies, the current valuation is near the high end of the stock's ten-year range [1] Group 4: Software Industry - Guggenheim initiated coverage of Monday.com (MNDY) with a Buy rating and a price target of $250, indicating a 64% upside potential as the company transitions to a more sales-led, multi-product and upmarket approach [1] Group 5: Restaurant Industry - Truist initiated coverage of Cava Group (CAVA) with a Buy rating and a price target of $66, stating that Cava is the leading Mediterranean fast-casual concept and is expected to remain one of the fastest-growing restaurant chains [1]

Core Insights - Sarepta Therapeutics reported a third-quarter 2025 adjusted loss of $0.13 per share, missing the Zacks Consensus Estimate of $0.01 EPS, compared to an adjusted EPS of $0.43 in the same period last year [3][4] - Total revenues for the quarter were $399.4 million, down nearly 15% year over year, primarily due to lower sales of Elevidys, but still beating the Zacks Consensus Estimate of $352.6 million [4][5] - The company generated $131.5 million from Elevidys sales, a 27% decline year over year, attributed to the suspension of shipments to non-ambulatory patients amid safety concerns, yet this figure exceeded both the Zacks Consensus Estimate of $107 million and model estimates of $120 million [6][4] Financial Performance - Product revenues fell 14% year over year to $370.0 million, with $238.5 million generated from three PMO therapies, down 4% year over year, but beating estimates [5][4] - Collaboration and other revenues associated with Elevidys supply to Roche were approximately $29.3 million, down nearly 22% year over year due to reduced shipment volumes [7] - Adjusted R&D expenses totaled $206.5 million, up 3% year over year, while adjusted SG&A expenses declined 23% to $77.1 million due to a restructuring plan [8] Guidance and Outlook - Sarepta expects at least $500 million in annual revenue from Elevidys infusions in the ambulant population for 2025, with fourth-quarter infusion volumes anticipated to be flat to slightly down [9] - The company projects combined adjusted SG&A and R&D expenses of $420-$430 million for the full year, including a $200 million milestone payment to Arrowhead Pharmaceuticals [10] - Recent estimates have trended downward, with a consensus estimate shift of -10.82% over the past month, indicating a downward shift in expectations [12][14] Industry Context - Sarepta Therapeutics is part of the Zacks Medical - Biomedical and Genetics industry, where Bristol Myers Squibb reported revenues of $12.22 billion for the last quarter, reflecting a year-over-year change of +2.8% [15] - Bristol Myers is expected to post earnings of $1.65 per share for the current quarter, representing a year-over-year change of -1.2% [16]

Core Viewpoint - Air Lease's recent earnings report indicates a mixed performance, with earnings per share missing estimates but showing year-over-year growth in total rental revenue from flight equipment [2][3]. Financial Performance - Air Lease reported Q3 2025 earnings per share of $1.29, missing the Zacks Consensus Estimate of $1.60, but improved 3.2% year over year [2]. - Total revenues reached $725.4 million, falling short of the Zacks Consensus Estimate of $737.3 million, yet grew 5.1% year over year [2]. - Revenues from the rental of flight equipment increased by 9% year over year to $681 million, driven by fleet growth and higher portfolio lease yield [3]. - Revenues from aircraft sales and other sources decreased by 32% year over year to $44 million due to lower sales activity [4]. - Operating expenses rose by 7.3% year over year to $600.9 million [4]. Asset and Debt Position - As of September 30, 2025, Air Lease owned 503 aircraft with a net book value of $29.5 billion, and the total fleet size was 781 [5]. - Cash and cash equivalents stood at $452.21 million, slightly down from $454.80 million in the previous quarter [6]. - Debt financing amounted to $20.2 billion, a slight decrease from $20.3 billion in the prior quarter [6]. Market Position and Outlook - Air Lease has a Zacks Rank of 4 (Sell), indicating expectations of below-average returns in the coming months [9]. - The company has a subpar Growth Score of D, but a strong Momentum Score of A, with an aggregate VGM Score of B [8]. - In comparison, Ryder, a peer in the same industry, reported a slight revenue increase and has a Zacks Rank of 4 (Sell) as well [10][12].

Wells Fargo analyst Michael Turrin initiates coverage on the stock at Overweight with a $280 price target. ...

Core Viewpoint - Wall Street analysts' recommendations significantly influence stock prices, but their reliability is questionable, particularly for Twilio (TWLO) [1][5]. Group 1: Brokerage Recommendations - Twilio has an average brokerage recommendation (ABR) of 1.85, indicating a consensus between Strong Buy and Buy, based on 27 brokerage firms [2]. - Of the 27 recommendations, 16 are Strong Buy (59.3%) and 2 are Buy (7.4%) [2]. Group 2: Limitations of Brokerage Recommendations - Solely relying on brokerage recommendations for investment decisions may not be advisable, as studies show they often fail to guide investors effectively [5]. - Brokerage firms tend to exhibit a positive bias in their ratings due to vested interests, leading to a disproportionate number of Strong Buy recommendations compared to Strong Sell [6][11]. Group 3: Zacks Rank vs. ABR - The Zacks Rank, which is based on earnings estimate revisions, is a more reliable indicator of near-term stock performance compared to ABR [8][12]. - Zacks Rank is updated more frequently and reflects timely changes in earnings estimates, unlike the potentially outdated ABR [13]. Group 4: Current Earnings Estimates for Twilio - The Zacks Consensus Estimate for Twilio's earnings for the current year remains unchanged at $4.81, suggesting stable analyst views on the company's earnings prospects [14]. - Due to the unchanged consensus estimate and other factors, Twilio holds a Zacks Rank of 3 (Hold), indicating a cautious approach despite the Buy-equivalent ABR [15].

Core Viewpoint - Brokerage recommendations, particularly for Carvana (CVNA), suggest a favorable outlook, but reliance solely on these recommendations may not be prudent due to potential biases from brokerage firms [5][11]. Group 1: Brokerage Recommendations - Carvana has an average brokerage recommendation (ABR) of 1.63, indicating a position between Strong Buy and Buy, based on 23 brokerage firms [2]. - Of the 23 recommendations, 14 are Strong Buy and 3 are Buy, accounting for 60.9% and 13% of all recommendations respectively [2]. Group 2: Limitations of Brokerage Recommendations - Studies indicate that brokerage recommendations often do not effectively guide investors towards stocks with the highest potential for price appreciation [5]. - Analysts from brokerage firms tend to exhibit a strong positive bias in their ratings, issuing five "Strong Buy" recommendations for every "Strong Sell" [6][11]. Group 3: Zacks Rank vs. ABR - The Zacks Rank, which classifies stocks from 1 (Strong Buy) to 5 (Strong Sell), is a more reliable indicator of near-term price performance compared to ABR [8][12]. - The Zacks Rank is based on earnings estimate revisions, which have shown a strong correlation with stock price movements, unlike the ABR that may not be up-to-date [13]. Group 4: Current Earnings Estimates for Carvana - The Zacks Consensus Estimate for Carvana's current year earnings remains unchanged at $4.85, suggesting stable analyst views on the company's earnings prospects [14]. - Due to the unchanged consensus estimate, Carvana holds a Zacks Rank of 3 (Hold), indicating a cautious approach despite the favorable ABR [15].

Core Viewpoint - Virtu Financial reported strong Q3 earnings, with adjusted EPS of $1.05, beating estimates by 8.3% and showing a 28% year-over-year increase [3][4]. Financial Performance - Adjusted net trading income reached $467 million, up 20.4% year over year, surpassing consensus estimates by 11.2% [3][4]. - Revenues from commissions and technology services rose 17.4% year over year to $154.5 million, exceeding estimates [5]. - Interest and dividend income was $127.4 million, a 1.7% increase year over year, but fell short of estimates [5]. - Adjusted EBITDA climbed 24.7% year over year to $267.8 million, with an improved margin of 57.3% [6]. Expense Analysis - Total operating expenses increased 15.2% year over year to $644.8 million, driven by higher brokerage fees, employee compensation, and other costs [7]. Segment Performance - Market Making segment reported adjusted net trading income of $344.1 million, a 19.5% year-over-year increase, and revenues of $668 million, up 15.8% [8]. - Execution Services segment achieved adjusted net trading income of $122.9 million, a 22.8% increase year over year, with total revenues rising 22.9% to $154.5 million [9]. Financial Position - As of September 30, 2025, cash and cash equivalents were $707.9 million, down 18.9% from the end of 2024, while total assets increased to $21.3 billion [10]. - Long-term borrowings rose to $2 billion from $1.7 billion at the end of 2024, and total equity increased by 14.4% to $1.7 billion [10]. Shareholder Returns - The company repurchased 0.5 million shares for $20.9 million in Q3 2025, with a remaining buyback capacity of $302.8 million [12]. - A cash dividend of 24 cents per share was announced, payable on December 15, 2025 [12]. Market Outlook - Following the earnings release, consensus estimates have increased by 32.09%, indicating positive investor sentiment [13]. - Virtu Financial holds a Zacks Rank 3 (Hold), suggesting an expectation of in-line returns in the coming months [15]. Industry Comparison - In the same industry, Synchrony reported a revenue increase of 2.4% year over year, with an EPS of $2.86 compared to $1.94 a year ago [16]. - Synchrony is expected to post earnings of $1.99 per share for the current quarter, reflecting a 4.2% year-over-year change [17].

Core Viewpoint - Electronic Arts (EA) reported disappointing Q2 fiscal 2026 earnings, missing estimates and showing a significant year-over-year decline in both earnings and revenues, raising concerns about future performance leading up to the next earnings release [2][10]. Financial Performance - EA's Q2 fiscal 2026 earnings were 54 cents per share, missing the Zacks Consensus Estimate of $1.27, and representing a 51.4% decline year-over-year [2]. - Revenues for the quarter were $1.84 billion, down 9.2% year-over-year, and below the consensus mark of $1.86 billion [2]. - Net bookings totaled $1.82 billion, a decrease of 12.6% year-over-year, with full-game net bookings at $700 million, down 15.9% [3]. Revenue Breakdown - Full-game revenues, accounting for 33.6% of total revenues, decreased 13.7% year-over-year to $618 million [4]. - Live services and other revenues, making up 66.4% of total revenues, fell 6.7% year-over-year to $1.221 billion [5]. - Revenues from consoles declined 11.8% year-over-year to $1.212 billion, while revenues from PC & Other and mobile platforms decreased by 3.3% and 4.2%, respectively [5]. Operating Metrics - GAAP gross profit decreased 11% year-over-year to $1.4 billion, with gross margin contracting by 200 basis points to 75.9% [6]. - Operating income on a GAAP basis fell 47.9% year-over-year to $200 million, with the operating margin dropping from 19% to 10.9% [7]. Balance Sheet and Cash Flow - As of September 30, 2025, EA had $1.26 billion in cash and short-term investments, down from $1.63 billion as of June 30, 2025 [8]. - The company generated $130 million in net cash from operating activities for the quarter and $1.87 billion for the trailing twelve months [8]. - EA repurchased 2.3 million shares for $375 million during the quarter, totaling 17.5 million shares for $2.5 billion over the trailing twelve months [8]. Dividend and Acquisition - EA declared a quarterly cash dividend of 19 cents per share, payable on December 23, 2025 [9]. - The company announced a definitive agreement for acquisition by an investor consortium at an enterprise value of approximately $55 billion, pending regulatory approvals and stockholder approval [10]. Market Outlook - Recent estimates for EA have shown an upward trend, with a consensus estimate shift of 5.63% [11]. - EA currently holds a Zacks Rank 3 (Hold), indicating expectations for an in-line return in the coming months [13]. Industry Comparison - EA is part of the Zacks Gaming industry, where Las Vegas Sands (LVS) has outperformed with a 16.1% gain over the past month, reporting revenues of $3.33 billion, a year-over-year increase of 24.2% [14].